Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13626301 | 1.00 | SRC (0.46) | SRCCYP2D6HPGDLMNAMAPK1 | |
| SCHEMBL3336638 | 0.87 | PTGS2 (0.55) | L3MBTL1 | |
| SCHEMBL241909 | 0.80 | SRC (0.56) | SRCCYP2D6LMNAMAPK1CES2 | |
| SCHEMBL28232530 | 0.80 | SRC (0.56) | SRCCYP2D6LMNAMAPK1CES2 | |
| SCHEMBL9394507 | 0.80 | SRC (0.50) | SRCCYP2D6LMNAMAPK1KMT2A | |
| SCHEMBL28232476 | 0.80 | SRC (0.56) | SRCCYP2D6LMNAMAPK1CES2 | |
| SCHEMBL1100039 | 0.80 | TRPA1 (0.42) | SRCCYP2D6HPGDLMNAKEAP1 | |
| SCHEMBL6969665 | 0.78 | SRC (0.48) | SRCCYP2D6LMNAMAPK1KMT2A | |
| SCHEMBL11183816 | 0.78 | SRC (0.48) | SRCCYP2D6LMNAMAPK1KMT2A | |
| SCHEMBL28307635 | 0.78 | SRC (0.54) | SRCCYP2D6LMNAMAPK1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114094098-A | Metal lithium powder composite material, preparation method, silica cathode and lithium ion battery | 上海卡耐新能源有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-107445880-B | A kind of trifluoromethyl modification AβThe synthetic method of -42 inhibitor structure analogs | 华南理工大学 | 2019-07-16 | — | — | CN | claimed |
| CN-109810573-A | Inorganic nano material prints ink and its preparation method and application | TCL集团股份有限公司 | 2019-05-28 | — | — | CN | claimed |
| CN-107445880-A | A kind of trifluoromethyl modifies AβThe synthetic method of 42 inhibitor structure analogs | 华南理工大学 | 2017-12-08 | — | — | CN | claimed |
| CN-104803951-A | Method for preparing high-quality epoxy cyclohexane by adopting micro-flow field reaction technology | NANJING UNIVERSITY OF TECHNOLOGY | 2015-07-29 | — | — | CN | claimed |
| CN-104710256-A | Cheap and efficient synthesis method of alpha-hydroxyketone compound | UNIV BEIJING | 2015-06-17 | — | — | CN | claimed |
| CN-101891569-B | Preparation method of alpha-aromatic ketone compound | UNIV WUHAN | 2013-07-24 | — | — | CN | claimed |
| CN-119040289-A | Amine dehydrogenase and encoding nucleic acid and application thereof | 河北工业大学 | 2024-11-29 | — | — | CN | disclosed |
| US-12084462-B2 | Spiro bicyclic inhibitors of menin-MLL interaction | JANSSEN PHARMACEUTICA NV (BE) | 2024-09-10 | — | — | US | disclosed |
| CN-112218844-B | Compound, resin, composition, resist pattern forming method, circuit pattern forming method, and resin purifying method | 三菱瓦斯化学株式会社 | 2024-04-26 | — | — | CN | disclosed |
| CN-115968391-B | Composition, resin, method for producing amorphous film, method for forming resist pattern, method for producing underlayer film for lithography, and method for forming circuit pattern | 三菱瓦斯化学株式会社 | 2024-04-26 | — | — | CN | disclosed |
| US-20240117102-A1 | POLYMER, COMPOSITION, METHOD FOR PRODUCING POLYMER, COMPOSITION FOR FILM FORMATION, RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, RADIATION-SENSITIVE COMPOSITION, COMPOSITION FOR UNDERLAYER FILM FORMATION FOR LITHOGRAPHY, METHOD FOR PRODUCING UNDERLAYER FILM FOR LITHOGRAPHY, CIRCUIT PATTERN FORMATION METHOD, AND COMPOSITION FOR OPTICAL MEMBER FORMATION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-04-11 | — | — | US | disclosed |
| US-20240117101-A1 | COMPOSITION FOR FILM FORMATION, RESIST COMPOSITION, RADIATION-SENSITIVE COMPOSITION, METHOD FOR PRODUCING AMORPHOUS FILM, RESIST PATTERN FORMATION METHOD, COMPOSITION FOR UNDERLAYER FILM FORMATION FOR LITHOGRAPHY, METHOD FOR PRODUCING UNDERLAYER FILM FOR LITHOGRAPHY, CIRCUIT PATTERN FORMATION METHOD, COMPOSITION FOR OPTICAL MEMBER FORMATION, RESIN FOR UNDERLAYER FILM FORMATION, RESIST RESIN, RADIATION-SENSITIVE RESIN, AND RESIN FOR UNDERLAYER FILM FORMATION FOR LITHOGRAPHY | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-04-11 | — | — | US | disclosed |
| US-8383094-B2 | inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-02-26 | — | — | US | disclosed |
| CN-102933555-A | Pyrazolecarboxamide derivatives and their use as microbiocides | SYNGENTA PARTICIPATIONS AG | 2013-02-13 | — | — | CN | disclosed |
| CN-101367715-B | Synthesis of substituted methyl benzylketone | YIYUAN XINQUAN CHEMICAL CO LTD | 2012-09-05 | — | — | CN | disclosed |
| WO-2011147690-A1 | PYRAZOLECARBOXAMIDE DERIVATIVES AND THEIR USE AS MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2011-12-01 | — | — | WO | disclosed |
| CN-101367715-A | Synthesis of substituted methyl benzylketone | YIYUAN XINQUAN CHEMICAL CO LTD (CN) | 2009-02-18 | — | — | CN | disclosed |
| CN-101134739-A | Novel beta-lactam compound and preparation method and chemical uses thereof | CHANGCHUN DISCOVERY SCIENCES L (CN) | 2008-03-05 | — | — | CN | disclosed |
| US-4215044-A | FLUORINATION OF AN UNSATURATED SILANOL COMPOUND WITH A PERHALOGENATED HYPOFLUORITE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12084462-B2 | Spiro bicyclic inhibitors of menin-MLL interaction | BMI1, MLLT1, MEN1 | SRC 2402/4885CYP2D6 3831/4885HPGD 1558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.